This announcement is a separate document:
海通证券股份有限公司关于迈威（上海）生物科技股份有限公司变更部分募集资金专用账户并重新签订四方监管协议事项的核查意见
The verification opinion on the change of part of the fundraising special account and the re-signing of the four-party regulatory agreement by Maiwei (Shanghai) biotechnology Co., Ltd., submitted by Haitong Securities Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.